Antibiotic Resistance and What is ESG?

Antibiotic resistance is getting more worrisome. It's possible by 2050, antibiotic resistant super bugs could kill three times as many people could a year as during the worst parts of the COVID-19 pandemic . But there may be hope in the development of novel antibiotics. We discuss how this is related to the development of the COVID-19 vaccine. Then we finally put ESG ratings in their rightful place and tell you what they are REALLY used for.

The antibiotic story references research from our 2022 ESG Trends which can be viewed here: https://www.msci.com/research/2022-esg-trends-to-watch

The ESG ratings portion references an interactive chart which can be fond here: https://www.msci.com/research/2022-esg-trends-to-watch/esg-ratings-in-rightful-place

Host: Mike Disabato

Guests: Julia Giguere-Morello, ESG Research; Laura Nishikawa, ESG Research